gross profit bridgeinconsistent2023-06-30
Withheld: cost revenue, revenue could not be reconciled with the rest of this filer’s statement.
Revenue
$3.73B
Fiscal year ended 2026-06-30Operating income
$451.60M
Fiscal year ended 2026-06-30Free cash flow
$313.90M
Fiscal year ended 2026-06-30LABCORP HOLDINGS INC. (LH) reported revenue of $3.73B and net income of $298.70M for the fiscal year ended 2026-06-30. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from LABCORP HOLDINGS INC.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Services-Medical Laboratories.
Income
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.73B | $3.54B | $3.52B | $3.56B | $3.53B | $3.35B | $3.33B | $3.28B | $3.22B | $3.18B |
| Cost of revenue | $2.62B | $2.52B | $2.52B | $2.54B | $2.48B | $2.40B | $2.43B | $2.38B | $2.29B | $2.28B |
| Gross profit | $1.11B | $1.01B | $993.20M | $1.03B | $1.05B | $948.00M | $896.30M | $904.40M | $926.40M | $897.30M |
| Operating income | $451.60M | $380.80M | $267.60M | $396.60M | $394.50M | $326.00M | $216.50M | $254.10M | $294.80M | $321.30M |
| Net income | $298.70M | $277.80M | $164.70M | $261.10M | $237.90M | $212.80M | $143.40M | $169.30M | $205.30M | $228.00M |
| Research & development | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Weighted-average diluted shares | shares 82.00M | shares 82.90M | Unavailable | shares 83.70M | shares 83.90M | shares 84.30M | Unavailable | shares 84.40M | shares 84.30M | shares 84.70M |
| Pretax income | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Income tax expense | $87.30M | $41.70M | $25.70M | $75.50M | $66.40M | $62.20M | $40.20M | $41.00M | $62.10M | $69.10M |
| Diluted EPS | $3.64 | $3.35 | Unavailable | $3.12 | $2.84 | $2.52 | Unavailable | $2.00 | $2.43 | $2.69 |
| Selling, general & administrative | $577.20M | $551.00M | $538.60M | $552.40M | $579.30M | $546.00M | $595.20M | $568.60M | $557.80M | $508.40M |
| General & administrative | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Selling & marketing | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Balance
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $141.80M | $981.10M | $532.30M | $598.10M | $647.30M | $369.40M | $1.52B | $1.52B | $265.10M | $99.30M |
| Total assets | $18.53B | $19.09B | $18.39B | $18.26B | $18.06B | $17.60B | $18.38B | $18.61B | $16.71B | $16.53B |
| Current assets | $3.81B | $4.56B | $4.02B | $4.08B | $4.09B | $3.79B | $4.81B | $4.91B | $3.57B | $3.46B |
| Total liabilities | $9.91B | $10.34B | $9.76B | $9.55B | $9.57B | $9.28B | $10.31B | $10.43B | $8.69B | $8.56B |
| Current liabilities | $2.12B | $2.64B | $2.82B | $2.63B | $2.72B | $2.06B | $3.33B | $3.41B | $4.06B | $3.94B |
| Total equity incl. NCI | $8.61B | $8.73B | $8.62B | $8.70B | $8.47B | $8.31B | $8.05B | $8.17B | $8.01B | $7.96B |
| Temporary (mezzanine) equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Inventory | $562.20M | $497.70M | $534.70M | $521.50M | $508.10M | $488.30M | $493.20M | $483.10M | $441.80M | $475.00M |
| Accounts receivable | $2.34B | $2.29B | $2.10B | $2.11B | $2.12B | $2.12B | $1.94B | $2.06B | $2.09B | $2.08B |
| Goodwill | $7.03B | $6.96B | $6.79B | $6.68B | $6.55B | $6.42B | $6.37B | $6.48B | $6.22B | $6.22B |
| Long-term debt | $5.86B | $5.83B | $5.08B | $5.08B | $5.08B | $5.57B | $5.33B | $5.35B | $3.05B | $3.05B |
| Accounts payable | $688.50M | $695.70M | $840.80M | $668.50M | $793.00M | $717.90M | $875.80M | $660.90M | $760.60M | $695.50M |
Cash flow
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $445.50M | $191.50M | $614.20M | $387.20M | $620.60M | $18.50M | $777.20M | $277.30M | $561.10M | -$29.80M |
| Capital expenditures | $131.60M | $121.00M | $123.90M | $106.70M | $77.90M | $126.00M | $112.10M | $115.80M | $128.20M | $133.80M |
| Investing cash flow | -$366.20M | -$322.10M | -$389.90M | -$374.00M | -$94.10M | -$336.00M | -$209.60M | -$579.10M | -$185.00M | -$393.10M |
| Financing cash flow | -$919.90M | $580.50M | -$290.40M | -$59.50M | -$267.40M | -$839.70M | -$546.70M | $1.55B | -$210.00M | -$11.70M |
| Net change in cash | -$839.30M | $448.80M | -$65.80M | -$49.20M | $277.90M | -$1.15B | $1.40M | $1.25B | $165.80M | -$437.50M |
| Stock-based compensation | $34.90M | $31.70M | $29.70M | $29.20M | $34.10M | $32.80M | $27.30M | $27.00M | $30.80M | $31.60M |
| Common dividends paid | $58.70M | $61.20M | $59.30M | $59.90M | $59.90M | $61.60M | $60.10M | $60.50M | $60.40M | $62.10M |
| Common share repurchases | $353.80M | $98.00M | $225.00M | $25.00M | $200.00M | $0 | $75.10M | $75.00M | Unavailable | Unavailable |
| Depreciation & amortization | $179.00M | $173.30M | $173.00M | $171.00M | $170.30M | $166.80M | $170.60M | $161.50M | $156.90M | $154.50M |
Derived
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free cash flow | $313.90M | $70.50M | $490.30M | $280.50M | $542.70M | -$107.50M | $665.10M | $161.50M | $432.90M | -$163.60M |
| Gross margin | 29.8% | 28.7% | 28.2% | 28.8% | 29.7% | 28.3% | 26.9% | 27.6% | 28.8% | 28.2% |
| Operating margin | 12.1% | 10.8% | 7.6% | 11.1% | 11.2% | 9.7% | 6.5% | 7.7% | 9.2% | 10.1% |
| FCF margin | 8.4% | 2.0% | 13.9% | 7.9% | 15.4% | -3.2% | 20.0% | 4.9% | 13.4% | -5.2% |
| SBC / revenue | 0.9% | 0.9% | 0.8% | 0.8% | 1.0% | 1.0% | 0.8% | 0.8% | 1.0% | 1.0% |
| Current ratio | 1.80x | 1.73x | 1.42x | 1.55x | 1.50x | 1.84x | 1.44x | 1.44x | 0.88x | 0.88x |
| Revenue YoY growth | 5.8% | 5.8% | 5.6% | 8.6% | 9.5% | 5.3% | 9.8% | 7.4% | Unavailable | 4.6% |
| Net margin | 8.0% | Unavailable | 4.7% | 7.3% | 6.7% | Unavailable | 4.3% | 5.2% | Unavailable | Unavailable |
| R&D / revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| CapEx / revenue | 3.5% | 3.4% | 3.5% | 3.0% | 2.2% | 3.8% | 3.4% | 3.5% | 4.0% | 4.2% |
| Long-term debt / equity | 0.68x | Unavailable | 0.59x | 0.58x | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Effective tax rate | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open LH in the interactive workspace to inspect any figure back to its filing.
Source filings
10-Q · Filed 2026-08-05View SEC filing
10-Q · Filed 2026-05-04View SEC filing
10-K · Filed 2026-02-24View SEC filing
10-Q · Filed 2025-10-31View SEC filing
10-Q · Filed 2025-08-01View SEC filing
10-Q · Filed 2025-04-29View SEC filing
Reconciliation checks needing review
5 periods on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.
balance equationinconsistent2023-06-30
Withheld: assets, equity, liabilities could not be reconciled with the rest of this filer’s statement.
cash flow reconciliationreview2024-12-31
Operating, investing and financing flows differ from the reported change in cash by 19500000, beyond tolerance 7772000.00.
cash flow reconciliationreview2023-12-31
Operating, investing and financing flows differ from the reported change in cash by 6400000, beyond tolerance 5796000.00.
balance equationreview2023-09-30
Difference 19400000 exceeds tolerance 16886000.000. Presentation or filing-vintage differences need review.